Cargando…
Prognostic and Predictive Biomarkers in Non-Small Cell Lung Cancer Patients on Immunotherapy—The Role of Liquid Biopsy in Unraveling the Puzzle
SIMPLE SUMMARY: The introduction of immunotherapy modified the cancer treatment landscape, especially for non-small cell lung cancer (NSCLC). Unfortunately, only a subgroup of patients benefits from this therapy. Currently, the only validated companion diagnostic test for first-line immunotherapy in...
Autores principales: | Augustus, Elien, Zwaenepoel, Karen, Siozopoulou, Vasiliki, Raskin, Jo, Jordaens, Stephanie, Baggerman, Geert, Sorber, Laure, Roeyen, Geert, Peeters, Marc, Pauwels, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036384/ https://www.ncbi.nlm.nih.gov/pubmed/33918147 http://dx.doi.org/10.3390/cancers13071675 |
Ejemplares similares
-
The art of obtaining a high yield of cell-free DNA from urine
por: Augustus, Elien, et al.
Publicado: (2020) -
Circulating Cell-Free DNA and RNA Analysis as Liquid Biopsy: Optimal Centrifugation Protocol
por: Sorber, Laure, et al.
Publicado: (2019) -
Mass Spectrometry Imaging Reveals Neutrophil Defensins as Additional Biomarkers for Anti-PD-(L)1 Immunotherapy Response in NSCLC Patients
por: Berghmans, Eline, et al.
Publicado: (2020) -
A Multicenter Study to Assess EGFR Mutational Status in Plasma: Focus on an Optimized Workflow for Liquid Biopsy in a Clinical Setting
por: Sorber, Laure, et al.
Publicado: (2018) -
Immunohistochemistry as a screening tool for NTRK gene fusions: results of a first Belgian ring trial
por: De Winne, Koen, et al.
Publicado: (2020)